To investigate the effect of botulinum toxin type A (BTXA) on drooling and the morphologic change of the salivary gland in patients with cerebral palsy.
Method
Eight cerebral palsy patients suffering from severe drooling participated in this study. BTXA was injected into both submandibular and parotid glands under intravenous sedation and with ultrasound guidance (1 unit/gland/kg: maximum 100 units) in an outpatient or inpatient procedure. The severity of drooling was measured before injection and 3 weeks after injection using the Teacher Drooling Scale, the Drooling Score-severity, frequency and the Visual Analog Scale. To investigate the morphologic change of the salivary glands, the size of salivary glands were measured before injection and 3 weeks after injection using computed tomography of the neck. The measurement values were analyzed by Wilcoxon signed rank test.
Results
Statistically significant improvements were shown in all three parameters for assessing the severity of drooling after BTXA injections (p<0.05). Size of the salivary glands were significantly decreased at 3 weeks after BTXA injection (p<0.05).
Conclusion
Salivary gland injection with BTXA could be a useful treatment method to reduce drooling in patients with cerebral palsy and decreased size of salivary glands may partially explain the mechanism.
Citations
Citations to this article as recorded by
The Volumetric Effect of Botulinum Toxin Type A Injection on the Parotid Gland: A Randomized Controlled Trial Woo Shik Jeong, Dae Won Hong, Tae Joo Ahn, Hyun Ho Han Plastic & Reconstructive Surgery.2024; 153(2): 337. CrossRef
Botox for the prevention of radiation‐induced Sialadenitis and xerostomia in head and neck cancer patients: A pilot study Chad Alexander Nieri, Ezer Haim Benaim, Yanhui H. Zhang, Franklin Garcia‐Godoy, Michael J. Herr, Weiqiang Zhang, David Schwartz, Kimberly K. Coca, John P. Gleysteen, Marion Boyd Gillespie Head & Neck.2023; 45(9): 2198. CrossRef
Conventional Remedy to Lou Gehrig’s Disease - Amyotrophic Lateral Sclerosis (ALS): A Rare Clinical Entity Deepak Gupta, Mayur Shiralkar, Vaishali Chaudhari Journal of Natural Remedies.2023; : 1563. CrossRef
Analgesia and sedation modalities used with botulinum toxin injections in children with cerebral palsy: a literature review Ahmed Nugud, Shahad Alhoot, Maha Agabna, Mohamed Babiker, Haitham Bashir Sudanese Journal of Paediatrics.2021; : 6. CrossRef
Cumulative Efficacy of Longitudinal Repeat Salivary Gland OnabotulinumtoxinA Injection Hannah Shoval, Kathleen Friel, Jared Levin, Heakyung Kim American Journal of Physical Medicine & Rehabilitation.2021; 100(8): 798. CrossRef
Clinical characteristics of dysphagic stroke patients with salivary aspiration Kwang Jae Yu, Donghwi Park Medicine.2019; 98(12): e14977. CrossRef
The Correlation Between Clinical Characteristics and Radionuclide Salivagram Findings in Patients With Brain Lesions: A Preliminary Study Donghwi Park, Seung Beom Woo, Dae Hee Lee, Kwang Jae Yu, Ju Young Cho, Jong Min Kim, Zeeihn Lee Annals of Rehabilitation Medicine.2017; 41(6): 915. CrossRef
Intérêt de l’échoguidage dans le traitement du bavage par injections de toxine botulique, notre expérience sur 10 ans M. Mailly, C. Rebours, P. Koskas, P. Klap, D. Ayache, M. Cohen Journal of Stomatology, Oral and Maxillofacial Surgery.2017; 118(1): 5. CrossRef